These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38959726)

  • 1. Binding sites and design strategies for small molecule GLP-1R agonists.
    Zhang H; Wu T; Wu Y; Peng Y; Wei X; Lu T; Jiao Y
    Eur J Med Chem; 2024 Sep; 275():116632. PubMed ID: 38959726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel approach to exploit Small-Molecule glucagon-like Peptide-1 receptor agonists with high potency.
    Wang X; Yun Y; Chen L; Guo S; Niu B; Fang J; Yuan Q; Shen J; Xie X; Wang K
    Bioorg Med Chem; 2024 Jun; 107():117761. PubMed ID: 38795571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R).
    Méndez M; Matter H; Defossa E; Kurz M; Lebreton S; Li Z; Lohmann M; Löhn M; Mors H; Podeschwa M; Rackelmann N; Riedel J; Safar P; Thorpe DS; Schäfer M; Weitz D; Breitschopf K
    J Med Chem; 2020 Mar; 63(5):2292-2307. PubMed ID: 31596080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a potential positive allosteric modulator of glucagon-like peptide 1 receptor through virtual screening and experimental study.
    Redij T; Ma J; Li Z; Hua X; Li Z
    J Comput Aided Mol Des; 2019 Nov; 33(11):973-981. PubMed ID: 31758355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New screening strategy and analysis for identification of allosteric modulators for glucagon-like peptide-1 receptor using GLP-1 (9-36) amide.
    Nakane A; Gotoh Y; Ichihara J; Nagata H
    Anal Biochem; 2015 Dec; 491():23-30. PubMed ID: 26341912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Aminothiophene derivatives as a new class of positive allosteric modulators of glucagon-like peptide 1 receptor.
    Redij T; McKee JA; Do P; Campbell JA; Ma J; Li Z; Miller N; Srikanlaya C; Zhang D; Hua X; Li Z
    Chem Biol Drug Des; 2022 Jun; 99(6):857-867. PubMed ID: 35313084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like Peptide-1 Receptor Agonists: A Class Update for Treating Type 2 Diabetes.
    Lovshin JA
    Can J Diabetes; 2017 Oct; 41(5):524-535. PubMed ID: 28942790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Overview, Advantages and Therapeutic Potential of Nonpeptide Positive Allosteric Modulators of Glucagon-Like Peptide-1 Receptor.
    Smelcerovic A; Lazarevic J; Tomovic K; Anastasijevic M; Jukic M; Kocic G; Anderluh M
    ChemMedChem; 2019 Mar; 14(5):514-521. PubMed ID: 30609277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Characterisation of Small Molecule Agonists Effect on the Human Glucagon Like Peptide-1 Receptor Internalisation.
    Thompson A; Stephens JW; Bain SC; Kanamarlapudi V
    PLoS One; 2016; 11(4):e0154229. PubMed ID: 27100083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Discovery and Development of Glucagon-Like Peptide-1 Receptor Agonists.
    Fang H; Niu B; Chen Q
    Curr Med Chem; 2024; 31(20):2921-2943. PubMed ID: 37062063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects.
    Zhao X; Wang M; Wen Z; Lu Z; Cui L; Fu C; Xue H; Liu Y; Zhang Y
    Front Endocrinol (Lausanne); 2021; 12():721135. PubMed ID: 34497589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.
    Nauck M
    Diabetes Obes Metab; 2016 Mar; 18(3):203-16. PubMed ID: 26489970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.
    Nauck MA; Meier JJ; Cavender MA; Abd El Aziz M; Drucker DJ
    Circulation; 2017 Aug; 136(9):849-870. PubMed ID: 28847797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Site-Specific Fatty Chain-Modified GLP-1 Receptor Agonist with Potent Antidiabetic Effects.
    Zhong X; Chen Z; Chen Q; Zhao W; Chen Z
    Molecules; 2019 Feb; 24(4):. PubMed ID: 30795583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric Modulators Enhancing GLP-1 Binding to GLP-1R via a Transmembrane Site.
    Wang J; Yang D; Cheng X; Yang L; Wang Z; Dai A; Cai X; Zhang C; Yuliantie E; Liu Q; Jiang H; Liu H; Wang MW; Yang H
    ACS Chem Biol; 2021 Nov; 16(11):2444-2452. PubMed ID: 34570476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel insights into the dynamics behavior of glucagon-like peptide-1 receptor with its small molecule agonists.
    Girdhar K; Dehury B; Kumar Singh M; Daniel VP; Choubey A; Dogra S; Kumar S; Mondal P
    J Biomol Struct Dyn; 2019 Sep; 37(15):3976-3986. PubMed ID: 30296922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles.
    Bueno AB; Showalter AD; Wainscott DB; Stutsman C; Marín A; Ficorilli J; Cabrera O; Willard FS; Sloop KW
    J Biol Chem; 2016 May; 291(20):10700-15. PubMed ID: 26975372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives in GLP-1 Research: New Targets, New Receptors.
    Cantini G; Mannucci E; Luconi M
    Trends Endocrinol Metab; 2016 Jun; 27(6):427-438. PubMed ID: 27091492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cinchonine, a Potential Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist, Lowers Blood Glucose and Ameliorates Non-Alcoholic Steatohepatitis.
    Xue H; Xing HJ; Wang B; Fu C; Zhang YS; Qiao X; Guo C; Zhang XL; Hu B; Zhao X; Deng LJ; Zhu XC; Zhang Y; Liu YF
    Drug Des Devel Ther; 2023; 17():1417-1432. PubMed ID: 37197367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-acting glucagon-like peptide-1 receptor agonists as add-on to insulin therapy in type 1 diabetes: A review.
    Albèr A; Brønden A; Knop FK
    Diabetes Obes Metab; 2017 Jul; 19(7):915-925. PubMed ID: 28211611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.